Influence of bile salts on cholesterol synthesis in the isolated perfused rat liver

Effects of bile salts on rat hepatic acyl CoA:cholesterol acyltransferase

Acyl CoA:cholesterol acyltransferase (EC2.3.1.26, ACAT), responsible for intracellular esterification of cholesterol, may play an important role in cholesterol trafficking within the cell, and thus, in maintenance of cellular cholesterol homeostasis. Bile acids are potential regulators of cholesterol trafficking in the liver. Therefore, the effect of bile salts on hepatic ACAT activity was studied in the perfused rat liver. ACAT activity was increased after liver perfusion with either taurocholate or taurochenodeoxycholate. However, addition of these bile salts at physiological concentrations in vitro had little effect on microsomal ACAT activity. The increase in hepatic ACAT activity due to perfusion with bile salts was accompanied by reduced accumulation of very low density lipoprotein cholesterol in the perfusate, but there was no effect on 3-hydroxy-3-methylglutaryl-CoA reductase activity. Hepatic ACAT activity was decreased after bile diversion for four hours in the intact animal. This treatment had no statistically significant effect on 3-hydroxy-3-methylglutaryl-CoA reductase activity. These data suggest that bile salts induce changes in hepatic compartmentation and traffic of cholesterol within the hepatocyte accompanied by response of ACAT activity to maintain cellular cholesterol homeostasis.

Cholesterol metabolism and sterol carrier protein-2 (non-specific lipid transfer protein)

Hepatic sterol carrier protein-2 significantly enhances the microsomal conversion of cholesterol to 7 alpha-hydroxy-cholesterol. In the present work we have attempted to correlate the hepatic content of sterol carrier protein-2 with bile acid formation. We have determined the amount of this protein in a variety of physiological and experimental conditions, in which the rate of bile acid synthesis varies over a wide range, viz. during fetal development, in inbred strains of rats with different rates of bile acid synthesis, and in rats fed diets containing drugs which modify the rate of bile acid synthesis. The outcome of these experiments does not support the idea that sterol carrier protein-2 has any association with bile acid synthesis. From our data we further conclude that hepatic sterol carrier protein-2 is an adaptable protein because its level increases during development from the fetal to the post-weaning stage of the rat and since it can be modulated by oral administration of certain drugs. Furthermore, it is demonstrated that the level of sterol carrier protein-2 varies between six inbred strains of rats.

Fecal bile acid excretion and liver cholesterol synthesis after sucralfate and cholestyramine administration in the rat

The relative ability of the resin cholestyramine and sucralfate (disucrose octasulfate) to bind bile acids in the gastro intestinal tract and increase fecal bile acid excretion has been studied in normal rats under standard diet. Plasma and liver cholesterol concentrations and in vitro cholesterol synthesis from 14C-acetate by liver slices, have been determined before and after one and three weeks of drug administration (0.5 or 1.0 g/100 g food). Plasma and liver cholesterol levels were unchanged after one week of treatment, but a moderate decrease in liver cholesterol content was observed after 3 weeks administration of cholestyramine and, to a lesser extent of sucralfate. Both drugs increase fecal bile acid excretion with a definitely higher effect of cholestyramine at either dose or period of administration. However, the resin produced a higher bile acid excretion after one week than after three weeks, whereas sucralfate effect increases with the time of administration. In vitro cholesterogenesis was clearly increased by cholestyramine and moderately by sucralfate although 14C-acetate incorporation into cholesterol was not quantitatively correlated to the amount of bile acid excreted in feces. The potential interest of sucralfate as bile acid sequestrant and hypocholesterolemic agent in man deserves further investigations.

Regulation and interaction of cholesterol, bile salt and lipoprotein synthesis in liver

The liver is the junction of several inter-organ metabolic cycles which are essential for the homeostasis of mammalian metabolism. Two of these are described in greater detail and their role in control of lipid metabolism will be presented. The fatty acid-triglyceride cycle is of particular importance for our understanding of the mechanisms governing serum lipid levels. This is due to the fact that the lipoprotein secreted by the liver in the course of this metabolic cycle - very low density lipoprotein - has a relatively long half-life in the plasma compartment. Data have been collected from the literature to show that different nutritional and pharmacological stimuli affecting serum lipid levels do so by interfering with the rate of very low density lipoprotein input into the plasma compartment. The enterohepatic circulation of steroids is another cycle which contributes to control of lipid metabolism. Data are presented which show that bile acids, the major steroids circulating in this cycle, exert direct feedback control of hepatic cholesterol synthesis. This characteristic of bile acids may explain why certain bile acids, when given orally, reduce serum cholesterol levels. Several clinical and experimental observations suggest a close relation between bile acid and triglyceride metabolism. It is characterized by an inverse relation between bile acid pool size and serum triglyceride levels. Moreover, a reduction of the bile acid pool size is accompanied by an enhanced hepatic fatty acid and triglyceride synthesis and secretion into blood. The molecular basis and physiological significance of these observations have still to be explored.(ABSTRACT TRUNCATED AT 250 WORDS)

Inhibition of cholesterol synthesis in rat liver by physiological doses of taurocholate

This report deals with the controversial problem whether bile acids exert a direct inhibitory effect on the rate of hepatic cholesterol synthesis. For this purpose rats have been provided with an 'extracorporeal bile duct', an experimental model which makes it possible to initiate a bile fistula two weeks after last surgery. In the animals that recovered completely from operative trauma, a 6-h infusion of 33.4 mumol sodium taurocholate x (100 g body weight)-1 x h-1, prevented the threefold rise of hepatic cholesterol synthesis following bile diversion. The rate of cholesterol synthesis was monitored by incorporation of [14C] acetate in vitro. There was no difference whether the animals were infused from 4--10 h (dark/light transition) or from 16--22 h (light/dark transition) besides the fact that taurocholate caused a more extensive inhibition during the light-dark transition. A parallel kind of response was observed for the activity of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (EC 1.1.1.34), the regulatory enzyme of cholesterol synthesis. A twofold rise of hepatic fatty acid synthesis was observed following bile diversion which was not seen in case of simultaneous bile salt infusion. It is concluded that bile salts exert direct feedback inhibition of hepatic cholesterol synthesis and that opposite results reported by other investigators are probably due to the infusion of too low doses of taurocholate.

Taurocholate inhibits the glucocorticoid-induced rise of 3-hydroxy-3-methylglutaryl-CoA reductase in primary culture of hepatocytes

The influence of taurocholate, the major bile acid of the rat, on 3-hydroxy-3-methylglutaryl-CoA reductase [mevalonate: NADP+ oxidoreductase (acylating CoA); EC 1.1.1.34], the regulatory enzyme of cholesterol synthesis, was studied in primary cultures of rat hepatocytes. The basal activity of the enzyme was not altered by adding up to 10 microM taurocholate to the culture medium. On the contrary, 1nM to 10 microM taurocholate caused a dose-dependent inhibition of enzyme activity within 6 h if added simultaneously with 10 microM dexamethasone. Because this glucocorticoid causes a cycloheximide-sensitive rise of 3-hydroxy-3-methylglutaryl-CoA reductase activity in this system the results are taken as evidence that bile salts inhibit the synthesis of the enzyme. The induction of tyrosine transaminase (L-tyrosine:2-oxoglutarate aminotransferase; EC 2.6.1.5) by dexamethasone was not influenced by taurocholate, which demonstrates that the glucocorticoid sensitivity of the cells was not impaired by the bile salt. It is concluded that there is a direct control of hepatic cholesterol synthesis by bile salts.

The mechanisms of and the interrelationship between bile acid and chylomicron-mediated regulation of hepatic cholesterol synthesis in the liver of the rat

Hepatic cholesterol synthesis is controlled by both the size of the bile acid pool in the enterohepatic circulation and by the amount of cholesterol reaching the liver carried in chylomicron remnants. These studies were undertaken to examine how these two control mechanisms are interrelated. When the size of the pool was systematically varied, the logarithm of the rate of hepatic cholesterol synthesis varied in an inverse linear fashion with the size of the taurocholate pool between the limits of 0 and 60 mg of bile acid per 100 g of body weight. The slope of this relationship gave the fractional inhibition of cholesterol synthesis associated with expansion of the taurocholate pool and was critically dependent upon the amount of cholesterol available for absorption from the gastrointestinal tract. Furthermore, the degree of inhibition of cholesterol synthesis in the liver seen with taurocholate feeding was reduced by partially blocking cholesterol absorption with beta-sitosterol even though the bile acid pool was still markedly expanded. In rats with diversion of the intestinal lymph from the blood, a five-fold expansion of the taurocholate pool resulted in only slight suppression of the rate of hepatic cholesterol synthesis, and even this inhibition was shown to be attributable to small amounts of cholesterol absorbed through collateral lymphatic vessels and (or) to a fasting effect. Similarly, the infusion of either taurocholate or a combination of taurocholate and taurochenate into rats with no biliary or dietary cholesterol available for absorption caused no suppression of hepatic cholesterol synthesis. Finally, the effect of changes in the rate of bile acid snythesis on hepatic cholesterol synthesis was examined. The fractional inhibition of cholesterol synthesis found after administration of an amount of cholesterol sufficient to raise the hepatic cholesterol ester content by 1 mg/g equalled only --0.36 when bile acid snythesis was increased by biliary diversion but was --0.92 when bile acid synthesis was suppressed by bile acid feeding. It is concluded that (a) bile acids are not direct effectors of the rate of hepatic cholesterol synthesis, (b) most of the inhibitory activity seen with bile acid feeding is mediated through increased cholesterol absorption, and (c) bile acids do have an intrahepatic effect in that they regulate hepatic cholesterol synthesis indirectly by altering the flow of cellular cholesterol to bile acids.

Taurolithocholate inhibits taurocholate uptake by isolated hepatocytes at low concentrations

The cholestatic bile acid taurolithocholate inhibits taurocholate uptake by isolated liver cells non-competitively. Inhibition is instantaneous and inversely related to the cell number in the incubate. The Ki amounts to 7 micron in the presence of 2 mg cellular protein per ml. Secretion of taurocholate by isolated liver cells is not affected by taurolithocholate up to a concentration of 50 micron. This indicates a difference between the carrier for taurocholate uptake and the carrier for taurocholate secretion. Inhibition of bile acid uptake of liver cells may be involved in the pathogenesis of lithocholate-induced cholestasis.

Action of three bile acids on hepatic and intestinal cholesterogenesis in the rat

Incorporation of [1(14)-C] acetate into cholesterol by subcellular particles from the liver and the small intestine of rats with a biliary diversion and a duodenal perfusion of sodium taurocholate, taurochenodeoxycholate or taurodehydrocholate, was studied in vitro. In the liver, taurochenodeoxycholate prevented the increase of cholesterol synthesis induced by biliary drainage. Taurocholate had no action on cholesterol synthesis at any time, day or night. Intestinal synthesis of cholesterol was reduced by taurocholate and taurochenodeoxycholate but was not modified by taurodehydrocholate infusion.

The regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the isolated perfused rat liver

The effect of perfusion of an isolated rat liver on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase was studied. In liver removed during the basal period of the diurnal cycle of enzyme activity, a 227 +/- 41% increase in enzyme activity occurred after 3 h of a plasma-free perfusion. This could be prevented by the addition of cycloheximide or pure cholesterol (dispersed with lecithin) to the perfusate. In contrast, the continuous addition of taurocholate or taurochenodeoxycholate, alone or in combination, at a variety of rates did not prevent the increase in enzyme activity. The added bile salts were efficiently extracted from the perfusate and excreted in the bile. The addition of these bile salts to a cholesterol-enriched perfusate did not alter the effect obtained with cholesterol alone. If the perfusate contained whole serum, the increase induced by perfusion in the basal period was smaller (88 +/- 27%) than with plasma-free perfusate. Again, the major bile salts of the rat failed to prevent the increase in enzyme activity induced by liver perfusion. If livers were removed and perfused at the height of the diurnal cycle of enzyme activity, the enzyme activity remained high (2 +/- 10% increase) rather than decreasing, as occurs in vivo. If cholesterol was added to these perfusions, a 52 +/- 4% decrease was induced. Bile salt addition induced no decrease. From the results it is concluded that the major bile salts are not direct regulators of hepatic cholesterol synthesis, but pure cholesterol, in the absence of bile salt or lipoprotein, is able to initiate the mechanism that represses hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.